Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1256376-21-2

Post Buying Request

1256376-21-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1256376-21-2 Usage

Chemical Properties

Colorless Oil

Check Digit Verification of cas no

The CAS Registry Mumber 1256376-21-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,6,3,7 and 6 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1256376-21:
(9*1)+(8*2)+(7*5)+(6*6)+(5*3)+(4*7)+(3*6)+(2*2)+(1*1)=162
162 % 10 = 2
So 1256376-21-2 is a valid CAS Registry Number.

1256376-21-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S,3S,4R)-2-azido-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]octadecan-1-ol

1.2 Other means of identification

Product number -
Other names (2S,3S,4R)-2-Azido-3,4-bis(tert-butyldimethylsilyl)-1,3,4-octadecanetriol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1256376-21-2 SDS

1256376-21-2Relevant articles and documents

Design and synthesis of new KRN7000 analogues

Sun, Man,Wang, Yuhang,Ye, Xin-Shan

, p. 7438 - 7447 (2013/08/23)

Presented by CD1d protein, KRN7000, a potent synthetic α- galactosylceramide, is known to stimulate the iNKT cells to produce different bioactive cytokines. Six new KRN7000 analogues, in which the amide bond in KRN7000 is replaced with O, NH, or ester groups incorporating variation of the acyl chain, or possessing an additional four-atom linker between the galactose and phytosphingosine moiety, were designed and synthesized. The synthetic compounds were evaluated for their ability to stimulate cytokine release and the preliminary structure-activity relationships were discussed. The synthetic strategy will benefit the construction of more KRN7000 derivatives, which may contribute to cytokine profile bias.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1256376-21-2